Numerous protein serum biomarkers have been suggested for diagnosing HCC, including α-L-fucosidase (AFU), γ-glutamyl transferase isoenzyme II (GGT-II), glypican-3 (GPC3), and hepatocyte growth factor (HGF)19–22. Here, HGF is linked to hepatocellular carcinoma.